Alfacell Corp.
300 Atrium Drive
Somerset,
NJ 08873
United States - Map
Phone: 732-652-4525
Fax: 732-652-4575
Web Site: http://www.alfacell.com
| Index Membership: | N/A | | Sector: | N/A | | Industry: | N/A | | Full Time Employees: | 6 |
|
| Alfacell Corporation, a biopharmaceutical company, primarily engages in the discovery and development of a class of therapeutic drugs for the treatment of cancer and other pathological conditions. Its proprietary drug discovery and development program consists of therapeutics developed from amphibian ribonucleases. The companys lead drug product candidate, ONCONASE is evaluated in human clinical trials for the treatment of various forms of cancer. It also focuses on new drug application for unresectable malignant mesothelioma. In addition, the company completed a Phase I clinical trial for the treatment of non-small cell lung cancer. Alfacell Corporation was founded in 1981 and is headquartered in Somerset, New Jersey. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Charles Muniz , 55
Chief Exec. Officer, Pres, Chief Operating Officer, Chief Financial Officer, Principal Accounting Officer |
$
87.00K |
$
0 | Dr. Michele Carbone M.D., Ph.D.,
Chairman of Thoracic Cancer Advisory Board |
N/A
| N/A | Mr. Tommy G. Thompson J.D., 67
Special Advisor |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.20% Nasdaq 
Profile
